Dates:
Competition closes: 28 August 2024 1:00pm BST
Application open: 17 July 2024
Selection Panel: November 2024
Contracts start: January 2025
Scope
The SBRI Healthcare Competition 25 Phase 1 funding competition invites breakthrough technologies to address challenges in antimicrobial resistance and aims to identify innovative solutions which have the potential to enter the NHS, social care and the wider market.
Specific Themes
- Point of care diagnostics, monitoring, and susceptibility testing
- Prescribing decision support and risk stratification
- Novel care delivery methods
- Infection prevention and control (IPC)
Projects that will not be funded
There are a number of technologies or types of solutions which are already available or will not make a significant impact on the challenges addressed in this brief. These are listed below.
- Any technologies that negatively impact staff workloads and do not support the workforce pressure, and that require high upfront capital investment by clinical services will be excluded.
- Systems and solutions that will not easily integrate or communicate with NHS/community setting systems.
- Technologies that will exacerbate health inequalities (including digital exclusion or data inequalities) and inequity of access to care e.g., digital technologies that are inaccessible to certain communities that experience digital poverty.
- Public awareness campaigns (including for education settings).
Eligibility
- The competition is open to single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public, and third sectors, including companies (large corporates and small and medium enterprises), charities, universities and NHS providers, as long as a strong commercial strategy is provided. Organisations based outside the UK or EU with innovations in remit for this call can apply as subcontractors of a lead UK/EU based organisation or via a UK or EU subsidiary.
- Collaborations are encouraged in the form of subcontracted services as appropriate.
Funding Rates
- Total eligible project costs: Phase 1 up to £100,000 (NET) and Phase 2 up to £800,000 (NET).
- Phase 1 Feasibility Studies: to show the technical and commercial feasibility of the proposed
- concept, duration 6 months
- Phase 2 contracts to develop and evaluate prototypes or demonstration units over a maximum of 12 months.
Projects will be 100% funded and suppliers for each project will be selected by an open competition process and retain the intellectual property rights (IPR) generated from the project, with certain rights of use retained by the NHS.
How PNO can support you
The UK team has a strong track record in securing some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK alone, we are responsible for the submission of more than 100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK national schemes and EU programmes.
